Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008057739> ?p ?o ?g. }
- W2008057739 abstract "Fragile X syndrome (FXS) is caused by the lack of expression of the fragile X mental retardation protein (FMRP), which results in intellectual disability and other debilitating symptoms including impairment of visual-spatial functioning. FXS is the only single-gene disorder that is highly co-morbid with autism spectrum disorder and can therefore provide insight into its pathophysiology. Lack of FMRP results in altered group I metabotropic glutamate receptor (mGluR) signalling, which is a target for putative treatments. The Hebb-Williams (H-W) mazes are a set of increasingly complex spatial navigation problems that depend on intact hippocampal and thus mGluR-5 functioning. In the present investigation, we examined whether an antagonist of mGluR-5 would reverse previously described behavioural deficits in Fmr1 KO mice. Mice were trained on a subset of the H-W mazes and then treated with either 20 mg/kg of an mGluR-5 antagonist, 2-Methyl-6-(phenylethynyl) pyridine (MPEP; n = 11) or an equivalent dose of saline (n = 11) prior to running test mazes. Latency and errors were dependent variables recorded during the test phase. Immediately after completing each test, marble-burying behavior was assessed which confirmed that the drug treatment was pharmacologically active during maze learning. Although latency was not statistically different between the groups, MPEP treated Fmr1 KO mice made significantly fewer errors on mazes deemed more difficult suggesting a reversal of the behavioural deficit. MPEP treated mice were also less perseverative and impulsive when navigating mazes. Furthermore, MPEP treatment reversed PSD-95 protein deficits in Fmr1 KO treated mice, whereas levels of a control protein (β-tubulin) remained unchanged. These data further validate MPEP as a potentially beneficial treatment for FXS. Our findings also suggest that adapted H-W mazes may be a useful tool to document alterations in behavioural functioning following pharmacological intervention in FXS." @default.
- W2008057739 created "2016-06-24" @default.
- W2008057739 creator A5037374427 @default.
- W2008057739 creator A5042681958 @default.
- W2008057739 creator A5087705146 @default.
- W2008057739 date "2014-03-06" @default.
- W2008057739 modified "2023-10-16" @default.
- W2008057739 title "2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice" @default.
- W2008057739 cites W1573292604 @default.
- W2008057739 cites W1593967463 @default.
- W2008057739 cites W1968311418 @default.
- W2008057739 cites W1969498835 @default.
- W2008057739 cites W1970755818 @default.
- W2008057739 cites W1971589262 @default.
- W2008057739 cites W1978122965 @default.
- W2008057739 cites W1981117745 @default.
- W2008057739 cites W1984617454 @default.
- W2008057739 cites W1985358653 @default.
- W2008057739 cites W1988037699 @default.
- W2008057739 cites W1995058974 @default.
- W2008057739 cites W1998232402 @default.
- W2008057739 cites W1999526036 @default.
- W2008057739 cites W2001065634 @default.
- W2008057739 cites W2002780348 @default.
- W2008057739 cites W2010209243 @default.
- W2008057739 cites W2012266823 @default.
- W2008057739 cites W2012280281 @default.
- W2008057739 cites W2014163893 @default.
- W2008057739 cites W2015703451 @default.
- W2008057739 cites W2017169966 @default.
- W2008057739 cites W2021455904 @default.
- W2008057739 cites W2021993883 @default.
- W2008057739 cites W2022296795 @default.
- W2008057739 cites W2026831615 @default.
- W2008057739 cites W2029439671 @default.
- W2008057739 cites W2031785254 @default.
- W2008057739 cites W2032366919 @default.
- W2008057739 cites W2033865869 @default.
- W2008057739 cites W2034277730 @default.
- W2008057739 cites W2034477738 @default.
- W2008057739 cites W2035631323 @default.
- W2008057739 cites W2039530316 @default.
- W2008057739 cites W2040009554 @default.
- W2008057739 cites W2040563577 @default.
- W2008057739 cites W2040936924 @default.
- W2008057739 cites W2042756959 @default.
- W2008057739 cites W2045611288 @default.
- W2008057739 cites W2050490622 @default.
- W2008057739 cites W2051956214 @default.
- W2008057739 cites W2052326665 @default.
- W2008057739 cites W2054091111 @default.
- W2008057739 cites W2064723730 @default.
- W2008057739 cites W2068273333 @default.
- W2008057739 cites W2069863147 @default.
- W2008057739 cites W2075724762 @default.
- W2008057739 cites W2082109123 @default.
- W2008057739 cites W2084889756 @default.
- W2008057739 cites W2085938114 @default.
- W2008057739 cites W2092491372 @default.
- W2008057739 cites W2094993063 @default.
- W2008057739 cites W2098756736 @default.
- W2008057739 cites W2099899772 @default.
- W2008057739 cites W2103709346 @default.
- W2008057739 cites W2104640135 @default.
- W2008057739 cites W2106727281 @default.
- W2008057739 cites W2108563170 @default.
- W2008057739 cites W2116276594 @default.
- W2008057739 cites W2123824748 @default.
- W2008057739 cites W2125608178 @default.
- W2008057739 cites W2126487937 @default.
- W2008057739 cites W2133810312 @default.
- W2008057739 cites W2136072088 @default.
- W2008057739 cites W2139898986 @default.
- W2008057739 cites W2143304413 @default.
- W2008057739 cites W2146760872 @default.
- W2008057739 cites W2149580098 @default.
- W2008057739 cites W2158520277 @default.
- W2008057739 cites W2159409509 @default.
- W2008057739 cites W2162400338 @default.
- W2008057739 cites W2162507760 @default.
- W2008057739 cites W2165896210 @default.
- W2008057739 cites W2167119720 @default.
- W2008057739 cites W2228459624 @default.
- W2008057739 cites W4319589137 @default.
- W2008057739 doi "https://doi.org/10.3389/fncel.2014.00070" @default.
- W2008057739 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3965849" @default.
- W2008057739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24701200" @default.
- W2008057739 hasPublicationYear "2014" @default.
- W2008057739 type Work @default.
- W2008057739 sameAs 2008057739 @default.
- W2008057739 citedByCount "28" @default.
- W2008057739 countsByYear W20080577392014 @default.
- W2008057739 countsByYear W20080577392015 @default.
- W2008057739 countsByYear W20080577392016 @default.
- W2008057739 countsByYear W20080577392017 @default.
- W2008057739 countsByYear W20080577392018 @default.
- W2008057739 countsByYear W20080577392019 @default.
- W2008057739 countsByYear W20080577392020 @default.
- W2008057739 countsByYear W20080577392021 @default.
- W2008057739 countsByYear W20080577392022 @default.